A detailed history of Envestnet Asset Management Inc transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 155,664 shares of APLS stock, worth $5.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
155,664
Previous 134,536 15.7%
Holding current value
$5.19 Million
Previous $5.16 Million 13.0%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$28.84 - $41.15 $609,331 - $869,417
21,128 Added 15.7%
155,664 $4.49 Million
Q2 2024

Aug 08, 2024

BUY
$38.07 - $59.71 $1.52 Million - $2.38 Million
39,931 Added 42.21%
134,536 $5.16 Million
Q1 2024

May 13, 2024

BUY
$55.39 - $72.47 $452,924 - $592,587
8,177 Added 9.46%
94,605 $5.56 Million
Q4 2023

Feb 13, 2024

BUY
$37.14 - $64.82 $221,762 - $387,040
5,971 Added 7.42%
86,428 $5.17 Million
Q3 2023

Nov 13, 2023

BUY
$23.65 - $89.22 $1.4 Million - $5.28 Million
59,152 Added 277.64%
80,457 $3.06 Million
Q2 2023

Aug 04, 2023

BUY
$76.68 - $93.31 $43,017 - $52,346
561 Added 2.7%
21,305 $1.94 Million
Q1 2023

May 11, 2023

BUY
$46.59 - $66.96 $966,462 - $1.39 Million
20,744 New
20,744 $1.37 Million
Q3 2022

Nov 10, 2022

BUY
$44.76 - $69.66 $183,695 - $285,884
4,104 New
4,104 $280,000

Others Institutions Holding APLS

About Apellis Pharmaceuticals, Inc.


  • Ticker APLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 109,865,000
  • Market Cap $3.66B
  • Description
  • Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...
More about APLS
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.